Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00603_DB00930_nanopub.RAT8LOupTHmvYoE6AxObWf1rvYLZ2qU5mJFu_qptdNsVE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00603_DB00930 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00603_DB00930 label "DDI between Medroxyprogesterone Acetate and Colesevelam - Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Progestins). Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness. [drugbank_resource:DB00603_DB00930]" assertion.
- drugbank_resource:DB00603_DB00930 identifier "drugbank_resource:DB00603_DB00930" assertion.
- drugbank_resource:DB00603_DB00930 title "DDI between Medroxyprogesterone Acetate and Colesevelam - Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Progestins). Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness." assertion.
- drugbank:DB00930 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00603_DB00930 assertion.
- drugbank:DB00603 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00603_DB00930 assertion.